Richard Naylor, DO
Orthopaedic Surgery · Waterloo, IANPI 1750317756
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Johnson & Johnson at 24.6% of the total. Reporting peaked in 2024 at $370 and has fallen 63.2% since, to $136 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in IA, where the typical reported total is $1,846.
Across 66 payments — averaging $25.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$416
- Stryker$287
- Next Science LLC$161
- Smith+Nephew$144
- Pacira Therapeutics, Inc.$126
- Bioventus LLC$83
- plus $474 from 20 others
What the payments were for
- Food & beverage$1,691100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $416 |
| Stryker | 9 | $287 |
| Next Science LLC | 2 | $161 |
| Smith+Nephew | 3 | $144 |
| Pacira Therapeutics, Inc. | 6 | $126 |
| Bioventus LLC | 4 | $83 |
| Ferring Pharmaceuticals Inc. | 4 | $68 |
| Axogen | 1 | $43 |
| Pfizer | 3 | $38 |
| Vertex | 2 | $32 |
| FX Shoulder Solutions, Inc | 1 | $30 |
| Zimmer Biomet | 2 | $28 |
| Radius Health, Inc. | 1 | $27 |
| Encore Medical, LP | 1 | $22 |
| Sonex Health, Inc. | 1 | $20 |
| Heraeus Medical, LLC. | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Amgen | 1 | $19 |
| Biomerieux Inc | 1 | $18 |
| Treace Medical Concepts, Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Solventum Corporation | 1 | $14 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $4 |
How this compares
$1,691 in reported general payments places this provider in the 45th percentile of 219 orthopaedic surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 213 | $6,337 |
| Meloxicam | 304 | $1,552 |
| Nabumetone | 20 | $428 |
| Tramadol Hcl | 21 | $133 |
| Amoxicillin | 145 | $129 |
| Clindamycin Hcl | 57 | $84 |
| Ciprofloxacin Hcl | 12 | $58 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $49 |
| Prednisone | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Waterloo
- Jay GintherWaterloo$15K
- Mark GorscheWaterloo$10K
- John CallaghanIowa City$23.3M
- Brian AdamsIowa City$865K
- Cesar de Cesar NettoIowa City$693K
- Lynn NelsonBelmond$285K
- Robert WestermannIowa City$182K
- Joseph BuckwalterIowa City$132K
- Brendan PattersonIowa City$122K
- Nicholas BedardIowa City$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.